Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

Clinical trial NCT02778685 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02778685
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7

Start date: 2016-09-30
Primary completion: 2025-10-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.